See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Liberation Day
Tariffs
Donald Trump
Trade War
Baseball
Natural Disasters
Republican Party
US Politics
Social Media
Senate
Democratic Party
U.S.-Canada Relations
Published • loading... • Updated

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

Summary by The Toronto Star
Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a leading cause of kidney transplant loss, with approximately ~23k patients living with all forms of AMR…

2 Articles

All
Left
1
Center
Right
The Toronto StarThe Toronto Star
Lean Left

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a leading cause of kidney transplant loss, with approximately ~23k patients living with all forms of AMR…

·Toronto, Canada
Read Full Article
UF Health, University of Florida HealthUF Health, University of Florida Health

Five Years After Receiving Transplant, Cole Empowering Patients at UF Health Ocala Neighborhood Hospital

All his life, Cole Tumey has lived with end-stage renal disease, a chronic kidney condition where the kidneys lose the ability to remove waste and balance…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Toronto Star broke the news in Toronto, Canada on Tuesday, March 11, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Canada

Canada

Ocala

Ocala

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal